Anti-cancer pioneers

March 9, 2007

Two Dundee University mathematicians have been awarded £160,000 by the Engineering and Physical Sciences Research Council to develop a new breed of "targeted" anti-cancer drugs. Fordyce Davidson and Mark Chaplain will work with biotechnology company Cyclacel Pharmaceuticals Inc.

Please login or register to read this article.

Register to continue

Get a month's unlimited access to THE content online. Just register and complete your career summary.

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments